BioxelPharma :: Investors / Directors and Officers

Management team

Message from the President and Chief Executive Officer
About us
Directors and Management team
News Releases
Contact for Investors
Financial and Regulatory Documents
Investor Information

Olivier Meyer, Ph.D.
President and CEO

Louis McGuire, CA
Vice President, Finance and Chief Financial Officer

Louis Estaque, MBA, Ph.D.
Vice President, Production

Thomas Warden, M.Sc.
Vice President, Sales, Marketing and Regulatory Affairs

Stock information

Symbol	TSX : BIP
Last trade	0.045
Open	0.035
Net change	+0.01
High	0.045
Low	0.035
52 week range	0.04 - 0.25
Volume	24,500
As of	2008-11-21 13:32 EST

Quotes are delayed. For informational purposes only.

Financial Documents

Annual Report 2007 (PDF: 2.07 Mb)

Directors

Pierre Lapalme (1) (3)
Chairman of the Board and Director Since 2002
Pharmaceutical Consultant

André P. Boulet, Ph.D. (1) (2)
Director Since 2000
President and Chief Executive Officer
PureCell Technologies Inc.

Rafick G. Henein, Ph.D., MBA
Director Since 2007
Pharmaceutical Consultant

Pierre Lacroix, Eng., Ph.D. (2) (3)
Director Since 1996
President, Gestion Pilac Inc.

Jacques Levesque, FCA (1) (2)
Director Since 2000
Vice President, Finance, Beaudier Inc.

(1) Member of the Audit Committee
(2) Member of the Corporate Financing and Development Committee
(3) Member of the Corporate Governance and Compensation Committee